Status:
TERMINATED
Propranolol Versus Prednisolone for Treatment of Symptomatic Hemangiomas
Lead Sponsor:
Nancy Bauman
Conditions:
Hemangioma of Infancy
Eligibility:
All Genders
2-6 years
Phase:
PHASE2
Brief Summary
Hemangiomas are relatively common lesions in infants. Most go away spontaneously after one year of life and do not need treatment. Others require treatment because they cause significant symptoms such...
Detailed Description
Infants with symptomatic hemangiomas will be enrolled. Magnetic resonance imaging will be completed before starting medication if the extent of the hemangioma is not evident on clinical examination al...
Eligibility Criteria
Inclusion
- infants with symptomatic hemangiomas
Exclusion
- asthma
- diabetes
- hypertension
- hypotension
- hypoglycemia
- liver failure
- previous treatment for hemangiomas
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT00967226
Start Date
July 1 2009
End Date
December 1 2014
Last Update
February 24 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's National Medical Center
Washington D.C., District of Columbia, United States, 20111